Top Mutual Funds
Agrochemicals firm Valiant Organics announced Q1FY23 Result :
- INR 2,660 Mn Operational Revenue
- INR 319 Mn Operating EBITDA
- 11.99% Operating EBITDA Margin
- 6.35% PAT Margin
- INR 169 Mn Profit After Tax
- INR 5.52/ Share EPS
- Q1-FY23 financials were impacted primarily due to the unfortunate blast at our Chlorination plant in Sarigam leading to shutdown for an extensive period of time, as well as subdued demand of our hydrogenation products and mandatory maintenance shut down at one of our Ammonolysis plant.
- The Sarigram plant has resumed partial operations since 21st July 2022, although it will take a few weeks to restore to normalcy due to ordering/delivery/erection of new machinery. The cost of damage and loss of business is covered under insurance.
- With regard to PAP, batch process is running as planned and have maintained an average run rate of 350 MT/month for Q1-FY23.
- The Pharma Intermediates project is still awaiting approvals. Water runs have been done and trial runs and production in a phased manner will commence immediately once the approvals are received.
- Price volatility stabilized to a certain extent in Q1-FY23 for our key raw materials and the positive impact of this will be seen in the quarters ahead if the market dynamics continue to remain the same.
FAQ’s on Valiant Organics Ltd Shares
